Skip to content

Verbetering in de diagnostiek van een doorbloedingsstoornis van de darm

The detrimental course of acute intestinal ischemia: Improvement of the diagnosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22199
Enrollment
120
Registered
2019-08-16
Start date
2020-06-30
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Intestinal Ischemia

Interventions

There will be no interventions in this study.

Sponsors

Academisch ziekenhuis Maastricht (azM)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age = 18 years All consecutive patients admitted to one of the participating medical centers emergency departments (ED) or at the intensive care unit (ICU) with clinical suspicion of acute intestinal ischemia, which is based on; o clinical manifestation; o physical examination by the physician; o laboratory measurements; o physician’s consideration to perform computed tomography (CT)-scan

Exclusion criteria

Exclusion criteria: Age = 18 years

Design outcomes

Primary

MeasureTime frame
The primary endpoint of the study is the early and accurate identification of presence and severity of acute intestinal ischemia in patients. The main study parameters are plasma biomarkers indicative for intestinal damage of patients suspected of acute intestinal ischemia.

Secondary

MeasureTime frame
Detection of volatile organic compounds (VOC) in exhaled air of patients suspected of acute intestinal ischemia.

Contacts

Public ContactAnnet Duivenvoorden

Maastricht University

annet.duivenvoorden@maastrichtuniversity.nl+31433881527

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)